News and features

Guidance recommending ICR-developed drug enzalutamide for treating metastatic prostate cancer is welcomed as the latest in a drug development golden age.

Cancers secrete an enzyme allowing them to hijack the surrounding healthy tissue in order to create the right conditions for their invasion and spread, new research finds.

Thalidomide therapy can extend the lives of myeloma patients, but it isn’t suitable for everyone with the disease, ICR researchers have found.

Chemical 'tags' on tumour DNA could help doctors decide which chemotherapy women with advanced ovarian cancer should get.

Chemotherapy extends lives of women with ovarian cancer when used in tandem with a new type of targeted treatment, study shows.

New modelling technique could allow doctors to track metabolic reactions in tumours in real time, say ICR researchers.

Research facilitated by Breast Cancer Campaign has identified the ten critical gaps that exist in breast cancer research.

Radiotherapy is an effective treatment for aggressive bladder cancer and could improve quality of life by sparing patients surgery, according to an ICR study.

For many people, the word ‘ultrasound’ conjures up images of nurses and doctors showing grainy footage of foetuses to pregnant women. Although imaging unborn babies is undoubtedly important, the technology has an incredible array of clinical uses outside the obstetrician’s office.

A new type of MRI scan could be used to monitor the effectiveness of an innovative new gene therapy for cancer, say scientists from The Institute of Cancer Research, London.

Using a new technique for examining stem cells, ICR scientists uncover dramatic differences in the gene expression levels between identical 'sister' pairs.

BACIT Limited, an innovative investment company with a financial model designed to help fund the battle against cancer has invested in its first drug development project